Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use
NCT01840085
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
261
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetic Foot Ulcer
Interventions
DRUG:
0.03% DSC127 topical gel
Sponsor
Integra LifeSciences Corporation
Collaborators
[object Object]